MICARDIS -----------------------WARNINGS AND PRECAUTIONS
• Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
Download MICARDIS -----------------------WARNINGS AND PRECAUTIONS
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION o …
docs.boehringer-ingelheim.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for
MEDICATION GUIDE PRADAXA (pra dax a) …
docs.boehringer-ingelheim.com(dabigatran etexilate mesylate) capsules Read this Medication Guide before you start taking PRADAXA and each time you get a refill. There may be new
DOSAGE FORMS AND STRENGTHS------------------ …
docs.boehringer-ingelheim.comPage 2 of 28 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Parkinson's Disease MIRAPEX tablets are indicated for the treatment of …
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
docs.boehringer-ingelheim.comFULL PRESCRIBING INFORMATION WARNING: ASTHMA-RELATED DEATH Long-acting beta2-adrenergic agonists (LABA) such as olodaterol, one of the active ingredients in STIOLTO RESPIMAT, increase the risk of asthma-related
HIGHLIGHTS OF PRESCRIBING INFORMATION …
docs.boehringer-ingelheim.com2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE OFEV is indicated for the treatment of idiopathic pulmonary fibrosis (IPF). 2 DOSAGE AND ADMINISTRATION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
docs.boehringer-ingelheim.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SPIRIVA HANDIHALER safely and effectively.
Prescribing Information - docs.boehringer …
docs.boehringer-ingelheim.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SPIRIVA RESPIMAT safely and effectively.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
docs.boehringer-ingelheim.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 EGFR Mutation-Positive, Metastatic Non-Small Cell Lung Cancer GILOTRIF is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer
HIGHLIGHTS OF PRESCRIBING INFORMATION Before initiating ...
docs.boehringer-ingelheim.com3 for volume contraction and correct volume status if indicated. Monitor for signs and symptoms of hypotension after initiating therapy and increase monitoring in clinical situations where volume contraction is expected [see Use in Specific Populations (8.5)].
PredniSONE Tablets USP, 1 mg, 2.5 mg, 5 mg, 10 mg, 20 mg ...
docs.boehringer-ingelheim.comacute nonspecific tenosynovitis, acute gouty arthritis, post-traumatic osteoarthritis, synovitis of osteoarthritis, epicondylitis. ... Increased dosage of rapidly acting corticosteroids is indicated in patients on corticosteroid therapy subjected to any unusual stress before, during and after the stressful situation.
Related documents
CALCIUM CHANNEL BLOCKER (CCB): Comparison Chart …
drofrx.com1 Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Bloc ker vs Diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.
Treatment of Hypertension: JNC 8 and More - PharmaSmart
pharma-smart.com(PL Detail-Document #300201: Page 6 of 6) Levels of Evidence 4. In accordance with the trend towards Evidence-Based Medicine, we are citing the LEVEL OF EVIDENCE for the statements we publish.